chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Twinrix on Aug2022; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 32-year-old female patient who received HAB (Twinrix) for prophylaxis.   Previously administered products included Twinrix (1st dose received on August 2022).   On an unknown date, the patient did not receive the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: Twinrix on Aug2022). The outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 28-MAR-2023 The pharmacist had a patient who received one dose of Twinrix and then Heplisav on January 2023. At the moment of the call, the health care professional (HCP) was not on the pharmacy, so it was not possible to had details such as Twinrix lot number or patient´s date of birth. The reporter consented to follow up via email.    Till the time of reporting, the patient did not receive 2nd dose of Twinrix (for Hepatitis A component), which led to incomplete course of vaccination
This spontaneous case, initially received from other health professional (nurse) on 06-Nov-2018, concerns a 52-year-old, adult female patient. On 31-Oct-2018, the patient was administered expired FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 195216, and expiry date: 30-Apr-2018]. The patient did not experience any adverse events after vaccine administration. The reporter assessed the case as non-serious. This case was linked to 201805215 due to same reporter. Non-significant follow-up received from nurse on 21-Nov-2018: The nurse confirmed that, the patient did not experience any adverse event after administration of the expired dose.
Loss of taste, smell and fatigue. I had a terrible cough. Fuzzy brain - still fuzzy. My oxygen saturations were low. Short of breath. And I just hurt all over - I felt like my body was hit by a truck. It hurt bad. Profuse sweating. We did telemed visit the first time. He prescribed Steroids and a z-pack. And had me take Vit D3, Vit C and zinc supplements. Those did not help with my symptoms. I called back on Monday, August 30th - and went in to the doctor's office and I was prescribed Doxycycline and another round of steroids and nebulizer treatments. Those treatments helped. I am getting there - as far as recovery.
Employee developed lightheadedness with tingling & numbness to BUE with palpitations 20 minutes after receiving Flu vaccine. Symptoms did not subside after laying flat for 30 minutes so was taken to ED for monitoring. Given one liter of fluid for dehydration & discharged.
full body rash; inflammation/skin is very inflamed; chills; hit flashes; huge headache; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 06Apr2021 at 10:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included vitiligo, premature ovarian failure (POF), eyebrow loss and low thyroid. The patient had no known allergies. The patient received unspecidied thyroid medication and estrogen patch within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 22:00, 12 hours after the shot, the patient had chills that wouldn't go away, then hit flashes, then a huge headache. On 12Apr2021, 6 days after the shot, the patient developed a full body rash and inflammation. But currently (at the time of this report) the patient has had a body rash for 3 days and her skin was very inflamed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the events chills, hit flashes, huge headache, full body rash, inflammation/skin was very inflamed were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild
One of the family member had the booster shot a week prior to contracting COVID-19.; One of the family member had the booster shot a week prior to contracting COVID-19.; Dose received: 3; This is a spontaneous report from a contactable consumer. This consumer reported for a male patient.  A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection,Batch/Lot number: Not reported) via an unspecified route of administration on an unspecified date as DOSE 3 (BOOSTER), SINGLE, via an unspecified route of administration on an unspecified date (Batch/Lot number: Not reported) as DOSE 2, SINGLE and via an unspecified route of administration on an unspecified date (Batch/Lot number: Not reported) as DOSE 1, SINGLE for COVID-19 immunisation. It was unknown if the patient took other vaccine in four weeks. It was unknown if the patient had covid prior vaccination and it was unknown if the patient was covid tested post vaccination. The patient medical history and concomitant medications were not reported. Family history included COVID-19 (youngest child did not receive the vaccine and also contracted COVID-19) start and stop date not reported. The reporter was made aware of a family who was vaccinated with the Pfizer-BioNTech vaccine and contracted COVID-19. One of the family member had the booster shot a week prior to contracting COVID-19 (unspecified date). The family was not hospitalized, and symptoms were not severe.The patient Dose received: 3 and it led to Booster on an unspecified date. Treatment taken for adverse events was unknown. The patient underwent lab test and procedure which included COVID-19 PCR test: positive on an unspecified date. Outcome of event One of the family member had the booster shot a week prior to contracting COVID-19 was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Felt nauseous about 10 minutes after injection. Returned home, sore arm, strong headache, fever and extreme sleepiness for 18 hours.  These symptoms have received by Day 3.  Increased dizziness and vertigo since Day 3. Currently Day4 and it?s getting worse. From sporadic to more consistent, more intense feeling.  Trouble getting up fast, cannot exercise.
pt recv vax; began vigorous crying few hr later;crying would suddenly be interrupted by stiffening & twitching of entire body w/ a rapid jaw movement lasting for a few sec then resumed crying;
From what I recall it felt like a sinus infection, coughing, headaches and cold symptoms. This lasted for a few days and then it was gone. I also had the postnasal drip until it started as a full cold "symptom". I did a home rapid test and then I treated myself at home.
arthritis, neurological symptoms-tingling, numbness, brain fog, muscle twithces, muscle pain, headaches, difficulty finding words, increased floaters in eyes
Patient reported a feeling of rapid heartbeat starting at 5pm 03/20/2018. By 03/21/2018, the feelings of rapid heartbeat had disipated. She noticed a rash approximately 6 inches round at site of injection around 8am 03/21/2018. The rash slowly receded and by 1pm 03/22/2018, the size of rash was 3 inches round. No other symptoms reported.
Initial non-serious report received from a purchaser on 18 October 2007.   A cluster of seven unidentified patients received injections of FLUZONE (lot number U2466AA) on various days at three different facilities.  The reporter indicated that many unusual reactions, which were more than local reactions, had been observed.  Five employees at a hospital location where FLUZONE was given with 23 gauge, one inch needles experienced arm swelling/cellulitis.  One individual received treatment with KEFLEX.  Two other facilities each had one patient with the same type of reactions.  Some patients complained of itching.  Some patients required doctor visits.  The reporter also indicated they have had many other patients with local reactions described as redness.  The reporter mentioned that they often prefill syringes for short periods of time.  Recovery status was not reported.  No additional information has been provided at the time of the report.  The reporter of this case is the same as for case 2007-03531, which involves cellulitis following receipt of FLUZONE, lot number U2446AA.
On Friday--four days after shot--I had fatigue and slight sore throat. This continued thru Tuesday when at work I felt the fatigue get much worse. The next 3 days I stayed home from work (Wed to Fri). I started improving at home on Wednesday and by Friday I felt good (no symptoms).
Every time recieved shots child was hospitalized with no explanation. This stopped when shots stopped. She at two was diganosed with development delay however current evaluation indicate autism and maybe mild retardation child was born early however was healthy and had no problems prior to shot. She had to be on apnea moniter during the first year after receving her second shot as she got older symptoms were less severe after shot and completly stopped when shots did.  06/14/07 Vax record received however no vax correspond to vaccine date on VAERS report. Submitted for scanning. 07/02/2007 MR received for 3 seperate admissions 5/25/1998-6/1/1998, 6/30/1998-7/8/1998, and 4/8-12/1999.  First admit for c/o fever and mild cough.  Admitted with initial dx of meningitis 2' (+) WBCs in CSF. Txd with IV abx x 7 days. Final DX 6/1/98:  Streptococcal bacteremia.  Aseptic meningitis. Mild candida dermatitis. Hx of prematurity.  2nd admit 6/30-7/8/1998 for c/o cough, cold sx, and fever. Apneic episode during spinal tap. Txd with IV abx then D/C on po abx.   Discharge DX 7/8/98:  Enterobacter bacteremia.  Resolved Candida dermatitis. 3rd admit 4/8-12/1999 for c/o fever and loose stools.  Pt was noted to be dehydrated with levated WBCs.  Discharge DX 4/12/99: Fever.  Gastroenteritis.  Dehydration.  Leukocytosis. Possible sinusitis.
Dizziness, Headache, Myalgia, Fever, Diarrhea, NauseaVomiting, arm soreness and swelling; Ageusia; Anosmia; rigors Narrative:
Shingles breakout on left hip and upper leg, and across left side of lower back...soreness in hip, tight muscles, sub temperature level with slight chills and general feeling of illness.  I am never sick so this is new.
JOINT PAIN; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced joint pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of joint pain was not reported. This report was non-serious. This case, from the same reporter is linked to 20210664038.
This spontaneous report was received from a pharmacist via a company representative refers to a male patient between 50-55 years. No medical history and concomitant medications were reported. On an unknown date approximately in April 2015, the patient was vaccinated with a dose of ZOSTAVAX (lot#K014853, expiry: 14-DEC-2015) to prevent shingles. On an unspecified date in April 2015, within a few days, but less than a week after the administration of the vaccine the patient developed swelling, redness, a hard lump and warmth around the injection site. The patient sought medical attention by contacting the pharmacist. Treatment received included ice and ibuprofen. On an unknown date in April 2015, the patient recovered from the events. Causality was not reported. Additional information has been requested.
severe site pain, left arm, radiated to my scapula through to the front of my shoulder where it is difficult to move my arm; After the first vaccine it started with severe site pain; difficult to move my arm; radiated to my scapula through to the front of my shoulder; This is a spontaneous report from a contactable other health care professional (patient). A 62-year-old non pregnant female patient received bnt162b2 ((PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: #EL0140), dose 1 via an unspecified route of administration, administered in Left Arm on 26Jan2021 03:15 (at age of 62-year-old) as dose 1, single for covid-19 immunization. The patient had no known allergies. Medical history included breast cancer, breast biopsy. Concomitant medications included SERTRALINE, ATORVASTATIN on an unknown date for unspecified indication. No other vaccine in four weeks. No covid prior vaccination and also no covid tested post vaccination. On an unspecified date, the patient experienced severe site pain, left arm, radiated to my scapula through to the front of my shoulder where it is difficult to move my arm, after the first vaccine it started with severe site pain, difficult to move my arm, radiated to my scapula through to the front of my shoulder. It was reported that she had to have a breast biopsy where a benign growth was removed. As of October where she had a breast MRI my breasts were clear from any growths. Treatment received for all the events included with cortisone injections and anti imflamatories. Adverse events resulted in physician or other health care professional office visit. The patient underwent lab tests and procedures which included magnetic resonance imaging: unknown on an unspecified date (my breasts were clear from any growths), polymerase chain reaction: negative on 04Jan2021 Nasal Swab. The outcome of event was not recovered.  No follow-up attempts are possible. No further information is expected.
pink itchy rash approximately 6 inches below injection site approximately 5 inches in diameter. rash started fading on day 3 after appearance, is still fading.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On 23-SEP-2016, the patient was inadvertently vaccinated with expired M-M-R II lot # K014833, expiry date: 14-SEP-2016 (dosing details was not reported). No adverse effect was reported. There were no product quality complaints (PQC) involved. Additional information has been requested.
Weakness Cough  Diarrhea  Fever 101.5 max Congestion
I had a little bit of swelling in the site of injection; Fever; I cannot make any movements because my neck make sound; I feel like my neck is going to break; I started, when turning my head back, making sound, it sounds very ugly; It hurts in my neck, where the spine begins in the head; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (I cannot make any movements because my neck make sound), MUSCULOSKELETAL DISCOMFORT (I feel like my neck is going to break), HEAD BANGING (I started, when turning my head back, making sound, it sounds very ugly), NECK PAIN (It hurts in my neck, where the spine begins in the head) and VACCINATION SITE SWELLING (I had a little bit of swelling in the site of injection) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history provided.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Aug-2021, the patient experienced MOBILITY DECREASED (I cannot make any movements because my neck make sound), MUSCULOSKELETAL DISCOMFORT (I feel like my neck is going to break), HEAD BANGING (I started, when turning my head back, making sound, it sounds very ugly) and NECK PAIN (It hurts in my neck, where the spine begins in the head). On an unknown date, the patient experienced VACCINATION SITE SWELLING (I had a little bit of swelling in the site of injection) and PYREXIA (Fever). The patient was treated with IBUPROFEN ongoing since an unknown date for Product used for unknown indication, at an unspecified dose and frequency. At the time of the report, MOBILITY DECREASED (I cannot make any movements because my neck make sound), MUSCULOSKELETAL DISCOMFORT (I feel like my neck is going to break), HEAD BANGING (I started, when turning my head back, making sound, it sounds very ugly), NECK PAIN (It hurts in my neck, where the spine begins in the head), VACCINATION SITE SWELLING (I had a little bit of swelling in the site of injection) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Slept a lot after administration, belly pain with being inconsolable, diarrhea, diaper rash.
11/18/09 4 cm area with redness, swelling and warmth to R thigh. 11/19/09 effected area is larger, child is afebrile, BACTRIM 100mg BID x 10days given by Dr. 11/20/09 mother contacted/symptoms are resolving. 11/24/09, symptoms have resolved completely.
This spontaneous report was received from a physician assistant refers to a no pregnant 17 year old female patient. Concurrent conditions, medical history and allergies were not reproted. It was reported that the patient received a two shot regimen where 08-JAN-1999, the patient was vaccinated with the first dose of VARIVAX (Merck) (strength, dose, route, anatomical location, lot number and expiration date were not reported) and 02-SEP-2009, the patient was vaccinated wight the second dose of VARIVAX (Merck) (strength, dose, route, anatomical location, lot number and expiration date were not reported). On 25-FEB-2015, the patient experienced a mild case of varicella and it was described that the patient had less than 25 lesions, no fever and no malaise. The reporter also stated that the patient's father had shingles and the physician's assistant believed this may be why the patient got the varicella. The patient sought medical attention through office visit and no treatment was given for the adverse event. The outcome of varicella was unknown. The relatedness between varicella and therapy with VARIVAX (Merck) was not reported. Additional information is not expected, because the reproter did not consent further follow up.
First  36 hrs -mild achiness, beginning about 3 days after vaccination- week and half of severe lower back and side pain. Beginning after lower back pain subsided and lasting several weeks - moderate to severe neck and shoulder pain and severe recurring headaches in back of head and dizziness.
Donor received the Tetanus Diphtheria Booster at 11:43 am, 7 mintes later, at 11:50m, the donor was pale and clamy.. Donor's blood pressure dropped to 90/62 from 112/80 that was taken earlier that day. Donor was provided Propel water and taken to an exam room to rest. After drinking the water, donor's blood pressure rose to 106/76. Donor left the cente with no incident.
Extreme dizziness and a whirlwind feeling 10 minutes after injection. Slight dizziness and headache for 2 days following. Beginning Monday 3/1 - rapid heart rate, hard palpitations, extreme dizziness, nausea, high BP, squeezing feeling in left chest, shooting pain thru underside of left arm and across collar bone lasting thru 3/6.
Narrative: A 48yo male with PMH of Obesity, HTN, Low Back pain Rhinitis, Shoulder Pain, Hypercholesterolemia, Neck Pain, Chronic PTSD, Low Back Pain, Cataplexy and Narcolepsy, Sleep Apnea, Eosinophilic Esophagitis and GERD A historical Adverse vaccine event of anaphylaxis was reported on April 29, 2021 by the documenting nurse's telephone contact note but no immunization record in the facility's system.
Bloody stool and rectal bleeding during every bowel movement every day starting a week after administration of the Gardasil vaccine. ER visit 3/15/2014. Colonoscopy 3/27/2014. Medications: Apriso (5 months) no treatment results. Prednisone (7 weeks) no treatment results. Mercaptopurine (2 months) elevated liver enzymes & not metabolizing drug effectively. Mercaptopurine combined with Allopurinol (2 weeks) no treatment results.
Had Flu snd Pneumonia vaccines in the same arm on the same day and now arm is red, swollen and painful with left axilla tenderness.  Patient was seen in the office, received steroid injection, steroid, antiobiotic and pain prescriptions.
PARALYSIS; TREMORED FOR ALMOST THREE MONTH; DID NOT WORK FOR TEN MONTHS; NUMEROUS SIDE EFFECTS; CHOLESTEROL HAVE GONE UP; A1C (HEMOGLOBIN) LEVEL HAVE GONE UP; This spontaneous report received from a patient concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: non smoker, and non alcohol user, and other pre-existing medical conditions included: The patient had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number, expiry were not reported) dose was not reported, 1 total administered on APR-2021 for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date in APR-2021, three days after receiving the vaccine patient presented to emergency room as patient was felt having a stroke. The patient had mention having paralysis. The patient's cholesterol and A1C (hemoglobin) level have gone up. The patient stated that having tremor for almost three months like patient had Parkinson's disease. The patient was not able work for ten months. The patient had a numerous side effect since vaccine. The patient stated that after 2.5 years still recovering and has a lot of side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tremored for almost three month, and did not work for ten months, and was recovering from paralysis, numerous side effects, cholesterol have gone up, and a1c (hemoglobin) level have gone up. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20231078595-Paralysis. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.